Search bioRxiv⌕ Search

Biology subjects

Hesser, L. A.

Publications and source records attributed to Hesser, L. A..

2 recordsLinked to original sources

TLR4 regulates proinflammatory intestinal immune responses mediated by an atopic gut microbiota

The increasing prevalence of food allergies has been causally associated with the depletion of allergy protective intestinal bacteria. However, few studies have investigated the role of the gut microbiota in promoting allergic responses. In a cohort of infants affected by cows milk allergy (CMA), we have identified a patient with a proinflammatory and atopic microbiota. In comparison to a healthy microbiota, this CMA-associated gut microbiota has increased abundance of Bacteroidetes, a Gram-negative phylum of bacteria that has been associated with increased incidence of allergy. Using this microbiota, we investigated the host-microbe interactions that mediate these intestinal inflammatory responses. To examine these interactions, we used mice with global and conditional abrogation in TLR4 signaling, since Gram- negative bacteria signal through this receptor via membrane-derived lipopolysaccharide (LPS). We show that this donors microbiota induces expression of serum amyloid A1 (Saa1) and other Th17-, B cell-, and Th2-associated genes in the ileal epithelium. Accordingly, this microbiota also induces Th17 cells, as well as regulatory T cell populations and fecal IgA. Importantly, we used both antibiotic treated SPF and rederived germ-free mice with a conditional mutation of TLR4 in the CD11c+ compartment to demonstrate that the induction of proinflammatory genes, fecal IgA, and Th17 cells is dependent on TLR4 signaling. Furthermore, metagenomic sequencing revealed that the CMA-associated gut microbiota also has increased abundance of LPS biosynthesis genes. Lastly, upon sensitization with {beta}-lactoglobulin, this CMA microbiota induces a TLR4-dependent mixed type 2/type 3 response in innate lymphoid cells (ILCs) during the early phases of allergic sensitization. Taken together, our results show that a Bacteroidetes-enriched microbiota with increased abundance of LPS genes promotes proinflammatory gene expression and a mixed type 2/type 3 response in a subset of infants with cows milk allergy. Paper HighlightsO_LIA cows milk allergy (CMA)-associated gut microbiota has an enrichment of Bacteroidetes, which is associated with atopy C_LIO_LIThe CMA-associated gut microbiota promotes intestinal inflammation, which includes inflammatory gene expression, induction of Th17 cells, and production of IgA C_LIO_LIProinflammatory responses induced by the CMA-associated gut microbiota are dependent on TLR4 signaling in various cellular compartments C_LIO_LIUpon sensitization, the CMA-associated gut microbiota induces an innate mixed type 2/type 3 inflammatory response C_LI

microbiology↗

Microbial metabolite butyrate-prodrug polymeric micelles promote gut health and treat food allergies

The microbiome modulates host immunity and aids in maintenance of tolerance in the gut, where microbial and food-derived antigens are abundant. Modern lifestyle practices, including diet and antibiotic use, have depleted beneficial taxa, specifically butyrate-producing Clostridia. This depletion is associated with the rising incidence of food allergy, inflammatory bowel diseases, and other noncommunicable chronic diseases. Although butyrate is known to play important roles in regulating gut immunity and maintaining epithelial barrier function, its clinical translation is challenging due to its offensive odor and quick absorption in the upper gut. Here, we have developed two polymeric micelle systems, one with a neutral charge (NtL-ButM) and one with a negative charge (Neg-ButM) that release butyrate from their polymeric core in different regions of the gastrointestinal tract when administered intragastrically to mice. We show that these butyrate-containing micelles, used in combination, restore a barrier-protective response in mice treated with either dextran sodium sulfate or antibiotics. Moreover, butyrate micelle treatment protects peanut-allergic dysbiotic mice from an anaphylactic reaction to peanut challenge and rescues their antibiotic-induced dysbiosis by increasing the abundance of Clostridium Cluster XIVa. Butyrate micelle treatment also reduces the severity of colitis in a murine model. By restoring microbial and mucosal homeostasis, these butyrate-prodrug polymeric micelles may function as a new, antigen-agnostic approach for the treatment of allergic and inflammatory disease.

bioengineering↗